GO:0008559 ABC-type xenobiotic transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008559 describes ATP-hydrolyzing transporters that export xenobiotics and other small molecules across membranes, using the energy of ATP hydrolysis.
• These transporters belong to the ATP-binding cassette (ABC) superfamily and include multidrug resistance proteins such as P-glycoprotein (ABCB1) and pleiotropic drug resistance (PDR) proteins.
• ABC-type xenobiotic transporters are found across all kingdoms of life, from bacteria to plants to humans, and they establish unique territories of small-molecule transport during development.
• In humans, these transporters are central to drug resistance in cancer and to the absorption, distribution, and excretion of drugs and toxins.
• In pathogens such as Haemonchus contortus, ABC transporter genes are linked to ivermectin resistance, making them targets for resistance-breaking strategies.
• Studying GO:0008559 requires combining transport assays, ATPase activity measurements, and CRISPR-based genetic models to dissect substrate specificity and regulation.
Description
ABC-type xenobiotic transporter activity (GO:0008559) is a molecular function that catalyzes the ATP-dependent export of xenobiotics and other small molecules across cellular membranes. This activity is carried out by members of the ATP-binding cassette (ABC) transporter superfamily, which couple ATP hydrolysis to the translocation of substrates against concentration gradients. The term encompasses a wide range of proteins historically known as multidrug resistance exporters, P-glycoproteins, and pleiotropic drug resistance (PDR) proteins. These transporters are essential for cellular detoxification, protection against environmental toxins, and the establishment of chemical barriers in tissues. In biomedical research, GO:0008559 is a focal point for understanding drug resistance in cancer and infectious diseases, as well as for optimizing drug delivery. The activity is also critical in plants and microorganisms, where it influences stress responses and the utilization of unusual carbon sources. Given its broad relevance, researchers need robust experimental models to study the genes encoding these transporters and their regulatory networks.
ABC-type xenobiotic transporter activity At A Glance
| GO ID | GO:0008559 |
|---|---|
| GO term | ABC-type xenobiotic transporter activity |
| Ontology | molecular_function |
| Synonym | ATPase-coupled xenobiotic transmembrane transporter activity; ATP-dependent xenobiotic transmembrane transporter activity; ATP phosphohydrolase (xenobiotic-exporting); MDR protein; multidrug resistance exporter; multidrug-resistance protein; PDR protein; P-glycoprotein; pleiotropic-drug-resistance protein; xenobiotic ABC transporter; xenobiotic transmembrane transporting ATPase activity |
| Major function | ATP-dependent export of xenobiotics and small molecules across membranes |
| Reaction | ATP + H2O + xenobiotic(in) = ADP + phosphate + xenobiotic(out) |
| Cofactor | Magnesium ions (Mg2+) required for ATP hydrolysis |
| Localization | Integral membrane proteins, typically plasma membrane or vacuolar membrane |
| Related superfamily | ATP-binding cassette (ABC) superfamily |
What Is GO:0008559?
According to the Gene Ontology, GO:0008559 is defined as the catalysis of the reaction: ATP + H2O + xenobiotic(in) = ADP + phosphate + xenobiotic(out). In other words, it is the ATP-powered transfer of a xenobiotic compound from the inside to the outside of a membrane, often against its concentration gradient. This activity is a type of primary active transport and is synonymous with terms such as ATPase-coupled xenobiotic transmembrane transporter activity, multidrug resistance exporter, and P-glycoprotein.
Why Is ABC-type xenobiotic transporter activity Important in Cell Biology?
GO:0008559 is critically important because it governs the efflux of a vast array of drugs, toxins, and endogenous metabolites, directly impacting drug efficacy and resistance in cancer and infectious diseases. In humans, ABC-type xenobiotic transporters such as P-glycoprotein (ABCB1) are major determinants of pharmacokinetics and multidrug resistance in tumors. In pathogens, these transporters contribute to anthelmintic resistance, as seen in Haemonchus contortus where ABC transporter genes are upregulated in ivermectin-resistant strains. Beyond medicine, these transporters are essential for plant stress tolerance and for bacterial degradation of environmental pollutants. Understanding their mechanism and regulation is therefore vital for developing inhibitors, optimizing drug regimens, and engineering organisms for bioremediation.
• Mediates multidrug resistance in cancer cells by exporting chemotherapeutic agents.
• Contributes to anthelmintic resistance in parasitic nematodes such as Haemonchus contortus.
• Regulates absorption, distribution, and excretion of drugs in the human body.
• Protects tissues from environmental toxins and xenobiotics.
• Enables bacterial utilization of unusual carbon sources like gamma-hexachlorocyclohexane.
• Plays a role in plant vacuolar transport and stress responses.
• Establishes unique territories of small-molecule transport during embryonic development.
• Serves as a target for chemical inhibitors to reverse drug resistance.
• Involved in metal-binding peptide transport in fission yeast.
• Provides a model for studying ATP-driven conformational changes in transporters.
What Happens During ABC-type xenobiotic transporter activity?
Substrate recognition and binding
In simple terms: The transporter first grabs the xenobiotic molecule from inside the cell.
ABC-type xenobiotic transporters possess a transmembrane domain that forms a substrate-binding pocket. This pocket recognizes a wide range of chemically diverse xenobiotics, often with low specificity, allowing a single transporter to handle multiple drugs. Substrate binding triggers conformational changes that prepare the transporter for ATP hydrolysis.
ATP binding and hydrolysis
In simple terms: The transporter uses ATP as an energy source to pump the molecule out.
The nucleotide-binding domains (NBDs) of the transporter bind ATP and hydrolyze it to ADP and phosphate. This hydrolysis provides the energy needed to drive the substrate across the membrane against its concentration gradient. The reaction is magnesium-dependent and is a hallmark of ABC transporters.
Conformational change and substrate translocation
In simple terms: The protein changes shape to push the molecule through the membrane.
ATP hydrolysis induces a conformational switch from an inward-facing to an outward-facing state, which translocates the bound xenobiotic to the extracellular side or into an intracellular organelle lumen. This alternating access mechanism is conserved across ABC transporters.
Substrate release and resetting
In simple terms: The molecule is released outside, and the transporter resets for another round.
After release of the substrate, the transporter returns to its original conformation, ready for another cycle. This resetting step is also ATP-dependent and ensures processive transport. In vacuolar systems, the transporter may work in concert with other pumps to maintain gradients.
Key Genes Involved in GO:0008559 ABC-type xenobiotic transporter activity
The following genes encode proteins that exhibit ABC-type xenobiotic transporter activity or are directly involved in its regulation and function, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ABCB1 (MDR1, P-glycoprotein) | ATP-dependent efflux of xenobiotics and drugs | Major mediator of multidrug resistance in cancer; target for inhibitors |
| ABCC1 (MRP1) | Multidrug resistance-associated protein; exports glutathione conjugates | Implicated in drug resistance and transport of organic anions |
| ABCG2 (BCRP) | Breast cancer resistance protein; exports xenobiotics | Determines pharmacokinetics of many drugs; stem cell marker |
| HMT1 (Schizosaccharomyces pombe) | Vacuolar membrane ABC transporter for metal-binding peptides | Model for peptide transport and heavy metal detoxification |
| linA (Sphingobium japonicum) | ABC-type transporter essential for gamma-hexachlorocyclohexane utilization | Bioremediation of organochlorine pesticides |
| PDR5 (Saccharomyces cerevisiae) | Pleiotropic drug resistance transporter | Model for antifungal resistance and substrate specificity |
| PDR11 (Saccharomyces cerevisiae) | Plasma membrane ABC transporter | Studied for sterol transport and drug efflux |
| ABCB4 (MDR3) | Phosphatidylcholine translocase | Mutations cause progressive familial intrahepatic cholestasis |
| ABCB11 (BSEP) | Bile salt export pump | Defects lead to cholestasis; target for drug-induced liver injury |
| ABCC2 (MRP2) | Canalicular multispecific organic anion transporter | Dubin-Johnson syndrome; drug disposition |
| ABCC3 (MRP3) | Organic anion transporter | Compensatory efflux in liver disease |
| ABCG5/ABCG8 | Sterol efflux transporters | Sitosterolemia; cholesterol regulation |
| Hc-ABC-1 (Haemonchus contortus) | ABC transporter linked to ivermectin resistance | Anthelmintic resistance mechanisms |
| Hc-ABC-2 (Haemonchus contortus) | ABC transporter linked to ivermectin resistance | Anthelmintic resistance mechanisms |
| AtPDR12 (Arabidopsis thaliana) | Pleiotropic drug resistance transporter | Lead tolerance and stress response |
| AtMRP3 (Arabidopsis thaliana) | Multidrug resistance-associated protein | Vacuolar transport of glutathione conjugates |
| CeABCB1 (C. elegans) | ABC transporter homolog | Developmental small-molecule transport |
| Sp-ABCG (sea urchin) | ABC transporter in embryonic mesoderm/endoderm | Patterning of small-molecule transport territories |
How Is ABC-type xenobiotic transporter activity Regulated?
The activity of ABC-type xenobiotic transporters is regulated at multiple levels. Transcriptional regulation often involves stress-responsive transcription factors that upregulate transporter genes upon exposure to xenobiotics or toxins. In cancer cells, overexpression of ABCB1 and other transporters can be driven by gene amplification or epigenetic changes. Post-translational modifications, including phosphorylation, can modulate transporter trafficking and activity. In plants, vacuolar transport energization is coordinated with proton pumps and stress signals. In Haemonchus contortus, ivermectin resistance is associated with increased expression of specific ABC transporter genes, suggesting selection for regulatory variants. Additionally, the availability of ATP and the lipid composition of the membrane can influence transporter function.
ABC-type xenobiotic transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ABCB1 | Multidrug resistance in cancer; blood-brain barrier function | Knockout cancer cell lines; overexpression in neuroblastoma cells |
| ABCB11 | Progressive familial intrahepatic cholestasis | Knock-in mouse models of patient mutations; hepatocyte-like cells |
| ABCB4 | Cholestasis; phospholipid transport defect | Knockout mice; point-mutation knock-in in hepatic cell lines |
| Hc-ABC-1 | Ivermectin resistance in Haemonchus contortus | CRISPR knockout in parasite cell lines; heterologous expression |
| ABCG2 | Drug resistance; hyperuricemia | Knockout cell lines; overexpression in kidney cells |
Multidrug resistance in cancer
Overexpression of ABC-type xenobiotic transporters such as ABCB1, ABCC1, and ABCG2 is a major cause of multidrug resistance in cancer, leading to chemotherapy failure. These transporters actively pump chemotherapeutic agents out of tumor cells, reducing intracellular drug concentrations below effective levels. Inhibitors of these transporters have been explored as chemosensitizers, though clinical success has been limited by toxicity and pharmacokinetic interactions.
Anthelmintic resistance in parasitic nematodes
In Haemonchus contortus, ABC transporter genes are upregulated in ivermectin-resistant isolates, implicating GO:0008559 in drug resistance. This resistance threatens livestock health and underscores the need for new anthelmintics or resistance-breaking strategies.
Inherited cholestatic liver diseases
Mutations in ABCB4 and ABCB11, which encode ABC transporters involved in bile component export, cause progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis. These disorders highlight the importance of ABC-type transporters in hepatic physiology and disease.
Neurodegeneration and blood-brain barrier
P-glycoprotein (ABCB1) at the blood-brain barrier limits the entry of neurotoxic xenobiotics and drugs into the brain. Altered function of these transporters has been implicated in neurodegenerative diseases and in variable drug responses.
From ABC-type xenobiotic transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ABCB1 restore drug sensitivity? | CRISPR knockout in multidrug-resistant cancer cell lines |
| How does a point mutation affect substrate specificity? | Point-mutation knock-in in ABCB1-expressing cells |
| Can a tagged transporter be tracked in live cells? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of ABCG2 confer resistance? | Overexpression in sensitive cell lines |
| What is the role of Hc-ABC-1 in ivermectin resistance? | CRISPR knockout in Haemonchus contortus larvae or heterologous expression |
| How does ABC transporter activity affect development? | Knockout in sea urchin embryos; rescue with mRNA |
How to Study the ABC-type xenobiotic transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent substrate efflux assay | Transport activity | Screening for inhibitors or resistance modulators |
| ATPase activity assay | ATP hydrolysis rate | Characterizing substrate-stimulated ATPase |
| CRISPR knockout screen | Gene essentiality for drug resistance | Identifying novel ABC transporter regulators |
| RNA-seq | Transcript levels of ABC transporters | Comparing resistant vs. sensitive strains |
| Proteomics | Protein abundance and modifications | Quantifying transporter expression |
| Cryo-EM | 3D structure of transporter | Understanding conformational states |
| Live-cell imaging | Subcellular localization and trafficking | Tracking tagged transporters |
| Transportomics | Global substrate profile | Identifying endogenous substrates |
Transport assays
Direct measurement of xenobiotic efflux can be performed using fluorescent substrates (e.g., rhodamine, calcein) and flow cytometry or fluorescence microscopy. ATPase activity assays measure the rate of ATP hydrolysis in the presence of substrates and inhibitors.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate sensitivity to xenobiotics, revealing novel regulators of GO:0008559. These screens are particularly powerful in cancer cell lines with acquired drug resistance.
Transcriptomics and proteomics
RNA-seq and quantitative proteomics can quantify expression changes of ABC transporter genes under xenobiotic exposure or in resistant strains. In Haemonchus contortus, transcriptome analysis identified ABC transporter genes associated with ivermectin resistance.
Structural biology and imaging
Cryo-EM and X-ray crystallography provide snapshots of transporter conformations, while live-cell imaging of tagged transporters reveals trafficking and localization. These methods help link structure to function.
How CRISPR Can Be Used to Study GO:0008559 ABC-type xenobiotic transporter activity
Knockout
CRISPR knockout of ABC transporter genes can abolish efflux activity, sensitizing cells to xenobiotics and revealing the contribution of specific transporters to drug resistance. Knockout models are also used to study the role of these transporters in development and physiology.
Point Mutation
Point mutations in ABC transporter genes can alter substrate specificity, ATP hydrolysis, or inhibitor binding. CRISPR-mediated point mutation knock-in allows precise modeling of clinical variants and functional dissection of catalytic residues.
Knock-in
Knock-in of tags (e.g., GFP, HA) or reporter genes at endogenous loci enables real-time tracking of transporter expression and localization without overexpression artifacts. Knock-in of disease-associated mutations creates isogenic models for drug testing.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate ABC transporter levels to study gain-of-function phenotypes, such as increased drug resistance or altered transport capacity. Overexpression models are useful for screening inhibitors.
How EDITGENE Supports ABC-type xenobiotic transporter activity Research
Researchers studying ABC-type xenobiotic transporter activity-related genes often need to determine whether a candidate gene is causally involved in drug resistance, transport, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for ABC-type xenobiotic transporter activity research.
Frequently Asked Questions About ABC-type xenobiotic transporter activity
What is ABC-type xenobiotic transporter activity?
It is an ATP-dependent molecular function that pumps xenobiotics and other small molecules out of cells or organelles, defined by GO:0008559.
What genes are involved in ABC-type xenobiotic transporter activity?
Key genes include ABCB1 (MDR1), ABCC1, ABCG2, ABCB11, ABCB4, and in pathogens such as Hc-ABC-1 and Hc-ABC-2.
How does ABC-type xenobiotic transporter activity contribute to drug resistance?
These transporters actively efflux chemotherapeutic drugs and anthelmintics, reducing intracellular concentrations and leading to resistance.
What is the reaction catalyzed by GO:0008559?
The reaction is ATP + H2O + xenobiotic(in) = ADP + phosphate + xenobiotic(out).
Which diseases are associated with ABC-type xenobiotic transporters?
They are linked to multidrug resistance in cancer, anthelmintic resistance, cholestatic liver diseases, and altered drug pharmacokinetics.
How can I study ABC-type xenobiotic transporter activity in the lab?
Common methods include fluorescent substrate efflux assays, ATPase activity assays, CRISPR screens, and transcriptomics.
What are synonyms for ABC-type xenobiotic transporter activity?
Synonyms include multidrug resistance exporter, P-glycoprotein, PDR protein, and xenobiotic transmembrane transporting ATPase activity.
Is ABC-type xenobiotic transporter activity found in plants?
Yes, plant PDR and MRP transporters exhibit this activity and are involved in stress responses and vacuolar transport.
Can CRISPR be used to study ABC-type xenobiotic transporter activity?
Yes, CRISPR knockout, point mutation knock-in, and overexpression models are powerful tools to dissect transporter function.
What is the role of ABC transporters in Haemonchus contortus?
ABC transporter genes are upregulated in ivermectin-resistant strains and contribute to anthelmintic resistance.
Conclusion
ABC-type xenobiotic transporter activity (GO:0008559) is a fundamental molecular function that protects cells from toxins and drives drug resistance in cancer and infectious diseases. The diversity of ABC transporters across species, from bacteria to humans, underscores their evolutionary importance and therapeutic potential. Continued research using CRISPR-based models and advanced omics will unravel the regulatory networks and structural determinants of these transporters, paving the way for new inhibitors and resistance-breaking strategies.
References
- 1. Endo R et al.. 2007. Identification and characterization of genes encoding a putative ABC-type transporter essential for utilization of gamma-hexachlorocyclohexane in Sphingobium japonicum UT26.. J Bacteriol 189(10):3712-20 PMID: 17369300
- 2. Seidel T et al.. 2013. Energization of vacuolar transport in plant cells and its significance under stress.. Int Rev Cell Mol Biol 304:57-131 PMID: 23809435
- 3. Reyes-Guerrero DE et al.. 2023. Assembly and Analysis of Haemonchus contortus Transcriptome as a Tool for the Knowledge of Ivermectin Resistance Mechanisms.. Pathogens 12(3) PMID: 36986421
- 4. Schrankel CS et al.. 2021. Early patterning of ABCB, ABCC, and ABCG transporters establishes unique territories of small molecule transport in embryonic mesoderm and endoderm.. Dev Biol 472:115-124 PMID: 33460641
- 5. Ortiz DF et al.. 1995. Transport of metal-binding peptides by HMT1, a fission yeast ABC-type vacuolar membrane protein.. J Biol Chem 270(9):4721-8 PMID: 7876244
